RxDoctor Payments Data

Alexis Lee

Family · Brentwood, TNNPI 1770010456

Payments from drug & device makers

$15,395in general payments, 2019–2025

Across 243 payments — averaging $63.35 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$8K
  • Daiichi Sankyo Inc.$3K
  • Regeneron Healthcare Solutions, Inc.$979
  • Novartis$466
  • Gilead$444
  • Johnson & Johnson$370
  • plus $3K from 42 others

What the payments were for

  • Consulting fees$1,3509%
  • Speaking & faculty fees$5,50036%
  • Travel & lodging$2,14014%
  • Food & beverage$6,30641%
  • Education$981%

General payments by program year

23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$15,395 in reported general payments places this provider in the 95th percentile of 6,706 family providers in Tennessee.

See all family providers in Tennessee

Most prescribed under Part D

DrugClaimsCost to plans & patients
Megestrol Acetate17$961
Dexamethasone21$517
Ondansetron Hcl11$443
Oxycodone Hcl17$361
Doxycycline Hyclate11$115
Potassium Chloride12$88
Olanzapine12$81
Tramadol Hcl17$54
Prednisone14$40

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCOlanzapine$19$8112 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 6,706 family providers in Tennessee.

Other family in Brentwood

See the full list for Tennessee

Where these figures come from

Is this you, or does something look wrong? →